Torrey Pines Investment and Innovestor’s Life Science Fund Launch Polku Therapeutics

Helsinki, Finland, August 29, 2024 — Torrey Pines Investment, a specialty life-science investment company based in San Diego, CA, and

READ MORE

Delisting of Calliditas Therapeutics AB (publ) from Nasdaq Stockholm

Nasdaq Stockholm has decided that Calliditas Therapeutics AB (publ) will be delisted from Nasdaq Stockholm. The last day of trading

READ MORE

CorFlow Therapeutics AG Completes €44 Million Series B Financing to Support the Advancement of a Novel Diagnostic and Drug Delivery Platform for Microvascular Obstruction (MVO) in Heart Attack Patients

Baar, Switzerland:   CorFlow Therapeutics AG (CorFlow) announced today that it has raised €44 million in Series B funding, co-led by

READ MORE

Neuraptive Therapeutics Receives FDA Breakthrough Therapy Designation for NTX-001 and Provides Update on the Advancements of NTX-001 for the Treatment of Peripheral Nerve Injury Requiring Repair

Chesterbrook, Pa., United States:   – Breakthrough Therapy designation for NTX-001 granted by FDA – Preparation is underway for the Phase

READ MORE